Pfizer (PFE), Allergan (AGN) in Talks About Blockbuster Deal - WSJ
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Allergen (AGN)/Pfizer (PFE) Deal Creates Mid-Teens Synergies in Year 2 - RBC Capital
October 29, 2015 10:40 AM EDTThe potential Allergan (NYSE: AGN)/Pfizer (NYSE: PFE) deal would bring attractive strategic and financial aspects and focus will shift to the likelihood of actually getting done if the price is right and management structure can be agreed... More
Pfizer (PFE) Confirms Discussions with Allergan (AGN)
October 29, 2015 10:10 AM EDTPfizer (NYSE: PFE) notes the announcement by Allergan (NYSE: AGN) that was released earlier today regarding a potential transaction between the companies. Pfizer confirms that it is in preliminary friendly discussions with Allergan in relation to a potential... More
Pfizer (PFE) Offering $375 - $400/Share for Allergan (AGN) Might Seal Deal - Leerink
October 29, 2015 10:07 AM EDTLeerink is out with commentary on Allergan (NYSE: AGN) following news that it and Pfizer (NYSE: PFE) are in talks over a potential deal.
Analyst Jason Gerberry is updating his Pfizer-Allergan model, which assumes at $375 per Allergan share takeover price. The analyst commented:
Following recent speculation that PFE (MP) and AGN are in discussions around a potential merger, we weigh in on (1) price; (2) people factor; (3) AGN M&A... More
Potential Allergan (AGN), Pfizer (PFE) Tie-Up No Surprise But May Take $400 to Get Done
October 29, 2015 9:50 AM EDTFollowing an eye-opening report late Wednesday from the WSJ, Allergan (NYSE: AGN) confirmed this morning that it has been... More
